All In Biotech

Free tool

FAERS Monitor: Caverject

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020379 or its brand name (Caverject, Alprostadil). Reports on generic versions are filed under their own applications.

Reports

2,865

Serious

2,024

71% of reports

Hospitalization

642

Death reported

244

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective638
  • off label use143
  • erection increased104
  • haemoglobin decreased83
  • lymphocyte count decreased79
  • pyrexia76
  • diarrhoea72
  • erectile dysfunction71
  • penile pain70
  • condition aggravated68
  • pain65
  • cardiac failure64
  • blood glucose increased63
  • injection site pain61
  • blood urea increased59

Reports by year received

View as table
YearReports
200476
200591
2006126
200785
200887
200947
2010363
2011185
2012128
201382
201467
2015127
2016180
2017206
2018139
2019184
2020141
2021118
202299
202391
2024101
202574
202667

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,294 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
erection increasedSignal104187.2154.618,601
penile painSignal70172.8136.711,514
lymphocyte count decreasedSignal7933.026.52,407
blood urea increasedSignal5926.020.21,388
erectile dysfunctionSignal7120.416.21,285
haemoglobin decreasedSignal835.94.8337
cardiac failureSignal645.94.6254
drug ineffectiveSignal6383.63.31,247
blood glucose increasedSignal632.51.953
condition aggravated681.61.317
pyrexia761.61.317
injection site pain611.51.19
off label use1431.21.05
diarrhoea720.80.73
pain650.80.64

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.